Go Pro
NASDAQ:WAY

Waystar (WAY) Stock Price, News & Analysis

Waystar logo
$25.66 -0.85 (-3.21%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$26.25 +0.59 (+2.30%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Waystar Stock (NASDAQ:WAY)

Advanced

Key Stats

Today's Range
$25.65
$26.95
50-Day Range
$20.79
$26.67
52-Week Range
$17.26
$40.35
Volume
2.82 million shs
Average Volume
2.33 million shs
Market Capitalization
$4.92 billion
P/E Ratio
36.66
Dividend Yield
N/A
Price Target
$34.67
Consensus Rating
Moderate Buy

Company Overview

Waystar Holding Corp. is a healthcare payments technology company that provides cloud-based software for managing administrative and financial processes across the healthcare system. Its platform connects healthcare providers, health plans and patients, helping organizations simplify complex transactions and improve the efficiency of the revenue cycle.

The company’s products and services include patient eligibility and coverage verification, claims management and submission, payment processing, prior authorization, denial and appeal management, patient billing, and related workflow automation. Waystar’s technology is designed to reduce manual administrative work, support cleaner claims, and help healthcare organizations collect and reconcile payments.

Waystar traces its history to the combination of healthcare technology businesses including Navicure and ZirMed, and operates primarily in the United States healthcare market. Matthew Hawkins serves as the company’s chief executive officer. Waystar began trading publicly on the Nasdaq under the symbol WAY in 2024.

AI Generated. May Contain Errors.

Waystar Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
87th Percentile Overall Score

WAY MarketRank™: 

Waystar scored higher than 87% of companies evaluated by MarketBeat, and ranked 49th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Waystar has received a consensus rating of Moderate Buy. The company's average rating score is 2.92, and is based on 2 strong buy ratings, 18 buy ratings, 4 hold ratings, and no sell ratings.

  • Upside Potential

    Waystar has a consensus price target of $34.67, representing about 35.1% upside from its current price of $25.66.

  • Amount of Analyst Coverage

    Waystar has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Waystar's stock forecast and price target.
  • Earnings Growth

    Earnings for Waystar are expected to grow by 14.29% in the coming year, from $1.47 to $1.68 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Waystar is 18.73, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.95.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Waystar is 18.73, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.79.

  • Price to Earnings Growth Ratio

    Waystar has a PEG Ratio of 1.00. PEG Ratios around 1 indicate that a company is correctly valued.

  • Price to Book Value per Share Ratio

    Waystar has a P/B Ratio of 1.27. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Waystar's valuation and earnings.
  • Percentage of Shares Shorted

    7.63% of the float of Waystar has been sold short.
  • Short Interest Ratio / Days to Cover

    Waystar has a short interest ratio ("days to cover") of 6.05.
  • Change versus previous month

    Short interest in Waystar has recently increased by 3.49%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Waystar does not currently pay a dividend.

  • Dividend Growth

    Waystar does not have a long track record of dividend growth.

  • News Sentiment

    Waystar has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 20 news articles for Waystar this week, compared to 5 articles on an average week.
  • Search Interest

    4 people have searched for WAY on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Waystar to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Waystar insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,206,524.00 in company stock.

  • Percentage Held by Insiders

    3.50% of the stock of Waystar is held by insiders.

  • Percentage Held by Institutions

    Waystar has minimal institutional ownership at this time.

  • Read more about Waystar's insider trading history.
Receive WAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Waystar and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

WAY Stock News Headlines

Teladoc Health (NYSE:TDOC) and Waystar (NASDAQ:WAY) Financial Review
Waystar (NASDAQ:WAY) Rating Lowered to Equal Weight at Barclays
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
Barclays Downgrades Waystar to Equalweight From Overweight
Waystar Shares Gain on Report of Potential Sale
Waystar (NASDAQ:WAY) CEO Matthew Hawkins Sells 82,500 Shares
See More Headlines

WAY Stock Analysis - Frequently Asked Questions

Waystar's stock was trading at $32.75 at the beginning of the year. Since then, WAY stock has decreased by 21.6% and is now trading at $25.66.

Waystar Holding Corp. (NASDAQ:WAY) posted its quarterly earnings data on Wednesday, July, 29th. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.03. Waystar's revenue for the quarter was up 18.1% compared to the same quarter last year.
Read the conference call transcript
.

Waystar (WAY) raised $968 million in an IPO on Friday, June 7th 2024. The company issued 45,000,000 shares at $20.00-$23.00 per share.

Top institutional investors of Waystar include Canada Pension Plan Investment Board (9.92%), BlackRock Inc. (9.09%), Advent International L.P. (5.77%) and Jupiter Topco LLC (1.50%). Insiders that own company stock include Luxco SA RL Derby, Canada Pension Plan Investment, Paul G Moskowitz, Matthew J Hawkins, T Craig Bridge, Eric L (Ric) Sinclair III, Christopher L Schremser, Steven M Oreskovich and Melissa F (Missy) Miller.
View institutional ownership trends
.

Shares of WAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Waystar investors own include NVIDIA (NVDA), Broadcom (AVGO), Advanced Micro Devices (AMD), PayPal (PYPL), Oracle (ORCL), Pfizer (PFE) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
7/29/2026
Today
9/19/2026
Next Earnings (Estimated)
11/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
NASDAQ:WAY
Previous Symbol
NASDAQ:WAY
CIK
1990354
Fax
N/A
Employees
1,700
Year Founded
2017

Price Target and Rating

High Price Target
$44.00
Low Price Target
$27.00
Potential Upside/Downside
+35.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.92
Research Coverage
24 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.70
Trailing P/E Ratio
18.73
Forward P/E Ratio
17.46
P/E Growth
1
Net Income
$112.09 million
Net Margins
11.18%
Pretax Margin
16.18%
Return on Equity
7.03%
Return on Assets
4.75%

Debt

Debt-to-Equity Ratio
0.36
Current Ratio
1.85
Quick Ratio
1.85

Sales & Book Value

Annual Sales
$1.10 billion
Price / Sales
4.48
Cash Flow
$1.95 per share
Price / Cash Flow
13.16
Book Value
$20.27 per share
Price / Book
1.27

Miscellaneous

Outstanding Shares
191,750,000
Free Float
185,037,000
Market Cap
$4.92 billion
Optionable
Optionable
Beta
0.16

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:WAY) was last updated on 9/19/2026 by MarketBeat.com Staff.
From Our Partners